LifeMap Sciences, A Subsidiary Of BioTime, Announces Release Of MalaCards Version 1.07 With Additional Types Of Clinical Significance From Clinvar And New Phenotypes From HPO

ALAMEDA, Calif.--(BUSINESS WIRE)--LifeMap Sciences, Inc., a subsidiary of BioTime, Inc., announced today the release of MalaCards, Version 1.07. The new release is available at http://www.malacards.org/. MalaCards is a database of human diseases and their annotations that is modeled on the architecture and richness of the popular GeneCards® database of human genes (http://www.genecards.org/). The database consolidates disease data from 65 sources and in this version contains 19,811 disease entries, 7,072 of which include associated genes. LifeMap Sciences holds the exclusive worldwide license to market MalaCards from Yeda Research and Development Company Ltd., the commercial arm of the Weizmann Institute of Science.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC